FORSCHUNGSZENTRUM BORSTEL ZENT has a total of 13 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Germany, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are LORANTIS LTD, SHANGHAI FUDAN ZHANGJIANG BIO and ZEALAND PHARMA A.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 6 | |
#2 | Australia | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Organic fine chemistry | |
#5 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Haas Helmut | 5 |
#2 | Haisch Karin | 5 |
#3 | Gronow Achim | 5 |
#4 | Falcone Franco | 5 |
#5 | Roeckendorf Niels | 3 |
#6 | Flad Hans-Dieter | 3 |
#7 | Bade Steffen | 3 |
#8 | Frey Andreas | 3 |
#9 | Gorris Hans-Heiner | 3 |
#10 | Schramm Gabriele | 3 |
Publication | Filing date | Title |
---|---|---|
DE102005051977A1 | New 2,4-dichlorophenoxyacetic acid derivatives and their use in diagnostic and analytical detection methods | |
DE102005051978A1 | Method for determining the cleavability of substrates | |
DE102005051976A1 | Kit for highly sensitive detection assays | |
DE10109844A1 | Immunomodulatory agents from parasitic worms and methods for their isolation | |
DE19822954A1 | Ki-67 gene antisense oligonucleotide | |
DE19744676A1 | Combination product for cancer therapy |